Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of Pieris Pharmaceuticals stock opened at $0.19 on Friday. Pieris Pharmaceuticals has a twelve month low of $0.14 and a […]
More Stories
Financial Survey: Hut 8 (NASDAQ:HUT) and Integrated Ventures (OTCMKTS:INTV)
Hut 8 (NASDAQ:HUT – Get Free Report) and Integrated Ventures (OTCMKTS:INTV – Get Free Report) are both finance companies, but...
Analysts Set HCA Healthcare, Inc. (NYSE:HCA) PT at $391.27
HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seventeen...
MarketWise (NASDAQ:MKTW) and Definitive Healthcare (NASDAQ:DH) Head to Head Review
Definitive Healthcare (NASDAQ:DH – Get Free Report) and MarketWise (NASDAQ:MKTW – Get Free Report) are both small-cap medical companies, but...
Alkermes plc (NASDAQ:ALKS) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the...
Insider Selling: Palo Alto Networks, Inc. (NASDAQ:PANW) EVP Sells $21,564,000.00 in Stock
Palo Alto Networks, Inc. (NASDAQ:PANW – Get Free Report) EVP Lee Klarich sold 120,000 shares of the stock in a...
Hewlett Packard Enterprise (NYSE:HPE) Receives Average Recommendation of “Moderate Buy” from Analysts
Hewlett Packard Enterprise (NYSE:HPE – Get Free Report) has received an average recommendation of “Moderate Buy” from the fourteen brokerages...